257 related articles for article (PubMed ID: 31959233)
1. Supervised exercise training and increased physical activity to reduce cardiovascular disease risk in women with polycystic ovary syndrome: study protocol for a randomized controlled feasibility trial.
Woodward A; Broom D; Dalton C; Metwally M; Klonizakis M
Trials; 2020 Jan; 21(1):101. PubMed ID: 31959233
[TBL] [Abstract][Full Text] [Related]
2. The effects of exercise on cardiometabolic outcomes in women with polycystic ovary syndrome not taking the oral contraceptive pill: protocol for a systematic review and meta-analysis.
Woodward A; Klonizakis M; Lahart I; Carter A; Dalton C; Metwally M; Broom D
Syst Rev; 2019 May; 8(1):116. PubMed ID: 31097035
[TBL] [Abstract][Full Text] [Related]
3. Supervised Aerobic Exercise Training and Increased Lifestyle Physical Activity to Reduce Cardiovascular Disease Risk for Women With Polycystic Ovary Syndrome: A Randomized Controlled Feasibility Trial.
Woodward A; Broom D; Dalton C; Metwally M; Klonizakis M
J Phys Act Health; 2022 Jun; 19(6):436-445. PubMed ID: 35606099
[TBL] [Abstract][Full Text] [Related]
4. The effectiveness of high intensity intermittent training on metabolic, reproductive and mental health in women with polycystic ovary syndrome: study protocol for the iHIT- randomised controlled trial.
Hiam D; Patten R; Gibson-Helm M; Moreno-Asso A; McIlvenna L; Levinger I; Harrison C; Moran LJ; Joham A; Parker A; Shorakae S; Simar D; Stepto N
Trials; 2019 Apr; 20(1):221. PubMed ID: 30992038
[TBL] [Abstract][Full Text] [Related]
5. Exercise, or exercise and diet for the management of polycystic ovary syndrome: a systematic review and meta-analysis.
Kite C; Lahart IM; Afzal I; Broom DR; Randeva H; Kyrou I; Brown JE
Syst Rev; 2019 Feb; 8(1):51. PubMed ID: 30755271
[TBL] [Abstract][Full Text] [Related]
6. Oxidised low-density lipoprotein concentration - early marker of an altered lipid metabolism in young women with PCOS.
Macut D; Damjanovic S; Panidis D; Spanos N; Glisic B; Petakov M; Rousso D; Kourtis A; Bjekic J; Milic N
Eur J Endocrinol; 2006 Jul; 155(1):131-6. PubMed ID: 16793959
[TBL] [Abstract][Full Text] [Related]
7. Lifestyle changes in women with polycystic ovary syndrome.
Moran LJ; Hutchison SK; Norman RJ; Teede HJ
Cochrane Database Syst Rev; 2011 Jul; (7):CD007506. PubMed ID: 21735412
[TBL] [Abstract][Full Text] [Related]
8. Effects of supervised aerobic training on the levels of anti-Mullerian hormone and adiposity measures in women with normo-ovulatory and polycystic ovary syndrome.
Al-Eisa E; Gabr SA; Alghadir AH
J Pak Med Assoc; 2017 Apr; 67(4):499-507. PubMed ID: 28420905
[TBL] [Abstract][Full Text] [Related]
9. Non-alcoholic fatty liver disease is associated with insulin resistance and lipid accumulation product in women with polycystic ovary syndrome.
Macut D; Tziomalos K; Božić-Antić I; Bjekić-Macut J; Katsikis I; Papadakis E; Andrić Z; Panidis D
Hum Reprod; 2016 Jun; 31(6):1347-53. PubMed ID: 27076501
[TBL] [Abstract][Full Text] [Related]
10. A behaviour change intervention to reduce sedentary time in people with chronic obstructive pulmonary disease: protocol for a randomised controlled trial.
Cheng SWM; Alison J; Dennis S; Stamatakis E; Spencer L; McNamara R; Sims S; McKeough Z
J Physiother; 2017 Jul; 63(3):182. PubMed ID: 28526329
[TBL] [Abstract][Full Text] [Related]
11. The effects of physical exercise on cardiometabolic outcomes in women with polycystic ovary syndrome not taking the oral contraceptive pill: a systematic review and meta-analysis.
Woodward A; Broom D; Harrop D; Lahart I; Carter A; Dalton C; Metwally M; Klonizakis M
J Diabetes Metab Disord; 2019 Dec; 18(2):597-612. PubMed ID: 31890686
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of Bushen Huatan Decoction combined with Baduanjin in the treatment of polycystic ovary syndrome with insulin resistance (IR-PCOS), kidney deficiency and phlegm dampness: study protocol for a randomized controlled trial.
Qian H; Xu W; Cui L; Wang R; Wang J; Tang M; Wei M; Wang L
Trials; 2021 Nov; 22(1):781. PubMed ID: 34743745
[TBL] [Abstract][Full Text] [Related]
13. A three-component cognitive behavioural lifestyle program for preconceptional weight-loss in women with polycystic ovary syndrome (PCOS): a protocol for a randomized controlled trial.
Jiskoot G; Benneheij SH; Beerthuizen A; de Niet JE; de Klerk C; Timman R; Busschbach JJ; Laven JS
Reprod Health; 2017 Mar; 14(1):34. PubMed ID: 28264692
[TBL] [Abstract][Full Text] [Related]
14. Lifestyle changes in women with polycystic ovary syndrome.
Lim SS; Hutchison SK; Van Ryswyk E; Norman RJ; Teede HJ; Moran LJ
Cochrane Database Syst Rev; 2019 Mar; 3(3):CD007506. PubMed ID: 30921477
[TBL] [Abstract][Full Text] [Related]
15. Effects of High Intensity Interval Training and Strength Training on Metabolic, Cardiovascular and Hormonal Outcomes in Women with Polycystic Ovary Syndrome: A Pilot Study.
Almenning I; Rieber-Mohn A; Lundgren KM; Shetelig Løvvik T; Garnæs KK; Moholdt T
PLoS One; 2015; 10(9):e0138793. PubMed ID: 26406234
[TBL] [Abstract][Full Text] [Related]
16. Relation of NT-probnp levels and cardiovascular disease risk factors in lean women with polycystic ovary syndrome.
Karadağ C; Yoldemir T
J Obstet Gynaecol; 2019 Nov; 39(8):1154-1159. PubMed ID: 31215274
[TBL] [Abstract][Full Text] [Related]
17. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
[TBL] [Abstract][Full Text] [Related]
18. Beneficial effects of a high-protein, low-glycemic-load hypocaloric diet in overweight and obese women with polycystic ovary syndrome: a randomized controlled intervention study.
Mehrabani HH; Salehpour S; Amiri Z; Farahani SJ; Meyer BJ; Tahbaz F
J Am Coll Nutr; 2012 Apr; 31(2):117-25. PubMed ID: 22855917
[TBL] [Abstract][Full Text] [Related]
19. Lifestyle changes in women with polycystic ovary syndrome.
Moran LJ; Hutchison SK; Norman RJ; Teede HJ
Cochrane Database Syst Rev; 2011 Feb; (2):CD007506. PubMed ID: 21328294
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
